Aligos Therapeutics, Inc. (ALGS)
NASDAQ·Healthcare·Biotechnology
$4.30
+1.18%
Mkt Cap $43.23M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+365.1%
Consensus $20.00 vs current $4.30
NASDAQ·Healthcare·Biotechnology
$4.30
+1.18%
Mkt Cap $43.23M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
+365.1%
Consensus $20.00 vs current $4.30